Express Scripts Holding Company
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Express Scripts Holding Company
Novartis gets some praise for being willing to embrace cost-effective drug prices, but health policy analysts are skeptical the industry would truly adopt the idea for its best-selling drugs, particularly if the appropriate guardrails were put in place to ensure broader budget impact was controlled. Holes were also poked in the way Novartis determined the total cost of drug utilization management on the US health system.
Sales at the Swiss major have returned to around 80%-90% of their pre-pandemic levels, according to CFO Harry Kirsch after unveiling a healthy set of second-quarter financials.
Entresto and Cosentyx continue to grow but investors will be looking to see if there are candidates in the current portfolio or pipeline that could join them in the mega-blockbuster club.
Study will examine prior authorization and other access restrictions at 15 of the largest US commercial payers for a group of 27 drugs.
- Pharmacy Services, PBMs
- Other Names / Subsidiaries
- Aristotle Holding, Inc.
- Cigna Corporation
- Express Scripts, Inc.
- Medco Health Solutions, Inc.